RaySearch Laboratories AB (RAY.B) Stock Statistics & Valuation Metrics

RaySearch Laboratories AB has a market cap or net worth of $10.56B. The enterprise value is ―.

RaySearch Laboratories AB has 28,627,798 shares outstanding. The number of shares has decreased by -2.65% in one year.

RaySearch Laboratories AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of RaySearch Laboratories AB is 36.39. RaySearch Laboratories AB’s PEG ratio is 2.54.

In the last 12 months, RaySearch Laboratories AB had revenue of 1.19B and earned 203.51M in profits. Earnings per share was 5.94.

In the last 12 months, operating cash flow was 485.23M and capital expenditures -217.54M, giving a free cash flow of 267.69M billion.

RaySearch Laboratories AB pays an annual dividend of kr3, resulting in a dividend yield of 0.21%

RaySearch Laboratories AB upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.

RaySearch Laboratories AB as a current ratio of 1.40, with Debt / Equity ratio of 53.83%

In the past 12 months, RaySearch Laboratories AB has paid 59.35M in taxes.

RaySearch Laboratories AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

RaySearch Laboratories AB has $462.74M in cash and marketable securities with kr471.93M in debt, giving a net cash position of $9.19M billion.

Gross margin is 85.52%, with operating margin of 21.85%, and net profit margin of 17.07%.

The average price target for RaySearch Laboratories AB is ―, which is 11.43% higher than the current price. The consensus rating is ―